{Reference Type}: Case Reports
{Title}: Malignant hyperthermia in severe COVID-19: 2 case reports.
{Author}: Ehteshami-Afshar S;Nikooie R;Reddy P;Chichra A;Siegel MD;
{Journal}: Emerg Crit Care Med
{Volume}: 1
{Issue}: 1
{Year}: 2021 Sep
暂无{DOI}: 10.1097/EC9.0000000000000013
{Abstract}: Malignant hyperthermia is a rare but potentially fatal condition. We present 2 cases of young patients with coronavirus disease 2019 (COVID-19) requiring intubation for hypoxic respiratory failure who both developed significant hyperthermia post intubation and were suspected to have malignant hyperthermia. However, the 2 patients had different responses to conservative management and dantrolene. These cases highlight the increased challenge imposed by intubation complications when managing patients with COVID-19.